VVP
GMAB icon

Venture Visionary Partners’s Genmab GMAB Stock Holding History

Venture Visionary Partners’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-949
Closed -$30.8K – 890
2022
Q2 		$30.8K Buy
+949
New +$30.7K ﹤0.01% 924

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Venture Visionary Partners's GMAB Position: Q3 2022 in Review

Venture Visionary Partners sold out of Genmab (GMAB) in Q3 2022, closing a stake of 949 shares — an estimated $30.8K sold.

Venture Visionary Partners first reported a position in GMAB in Q2 2022 and held it in 1 quarter. The position peaked at $30.8K in Q2 2022. 193 funds tracked by Wall St. Rank hold GMAB as of Q3 2022.

  • Venture Visionary Partners reported no remaining Genmab position as of Q3 2022 after selling out during the quarter.
  • Venture Visionary Partners sold 949 Genmab shares in Q3 2022, an estimated $30.8K.
  • Venture Visionary Partners first reported a position in Genmab in Q2 2022 and held it in 1 quarter.
  • Venture Visionary Partners's Genmab position peaked at $30.8K in Q2 2022.
  • 193 funds tracked by Wall St. Rank held Genmab as of Q3 2022.

Based on Venture Visionary Partners's 13F filing for Q3 2022, filed 14 Nov 2022.